Literature DB >> 18001787

Relationship between lower urinary tract symptoms and erectile dysfunction: results from the Boston Area Community Health Survey.

Sara T Brookes1, Carol L Link, Jenny L Donovan, John B McKinlay.   

Abstract

PURPOSE: We explored the association of lower urinary tract symptoms and erectile dysfunction in a racially and ethnically diverse random sample of men.
MATERIALS AND METHODS: The Boston Area Community Health Survey used a stratified, 2-stage cluster sample to recruit 2,301 men representative of Boston. Data were obtained on symptoms suggestive of a number of urogynecologic conditions, comorbidities, and lifestyle and psychosocial factors.
RESULTS: The percent of men reporting moderate/severe lower urinary tract symptoms, as measured by the American Urological Association symptom index, ranged from 8% in those 30 to 39 years old to 26% in those 70 to 79 years old. The prevalence of erectile dysfunction was high and it increased dramatically with age with 10% of 30 to 39-year-old and 59% of 70 to 79-year-old men reporting mild-moderate/moderate/severe symptoms. A strong association was observed between the American Urological Association symptom index and erectile dysfunction after adjusting for age. However, after adjusting for other symptoms and comorbidities evidence of this association became weak. Much stronger associations were seen with incontinence, which is not included in the American Urological Association symptom index, and symptoms suggestive of prostatitis. When considering the American Urological Association symptom index symptoms separately, only nocturia increased the severity of erectile dysfunction. Stratified analyses demonstrated similar associations across race/ethnicity groups.
CONCLUSIONS: Lower urinary tract symptoms and erectile dysfunction are common conditions in older men in the community. This study provides evidence to suggest that the previously observed association between erectile dysfunction and lower urinary tract symptoms may be primarily due to nocturia, incontinence and symptoms suggestive of prostatitis.

Entities:  

Mesh:

Year:  2007        PMID: 18001787     DOI: 10.1016/j.juro.2007.08.167

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

Review 1.  Stimulators and activators of soluble guanylate cyclase for urogenital disorders.

Authors:  Fabiola Z Mónica; Edson Antunes
Journal:  Nat Rev Urol       Date:  2017-11-14       Impact factor: 14.432

2.  Association of Preexisting Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients.

Authors:  Steven B Zeliadt; Scott D Ramsey; Arnold L Potosky; Neeraj K Arora; David K Blough; Ingrid Oakley-Girvan; Ann S Hamilton; Stephen K Van Den Eeden; David F Penson
Journal:  Patient       Date:  2008-07-01       Impact factor: 3.883

Review 3.  Marijuana, Alcohol, and ED: Correlations with LUTS/BPH.

Authors:  Granville L Lloyd; Brett Wiesen; Mike Atwell; Anna Malykhina
Journal:  Curr Urol Rep       Date:  2021-02-08       Impact factor: 3.092

4.  Cohort profile: the Boston Area Community Health (BACH) survey.

Authors:  Rebecca S Piccolo; Andre B Araujo; Neil Pearce; John B McKinlay
Journal:  Int J Epidemiol       Date:  2012-12-05       Impact factor: 7.196

5.  Association between body size and composition and erectile dysfunction in older men: Osteoporotic Fractures in Men Study.

Authors:  Pranav S Garimella; Misti L Paudel; Kristine E Ensrud; Lynn M Marshall; Brent C Taylor; Howard A Fink
Journal:  J Am Geriatr Soc       Date:  2013-01       Impact factor: 5.562

6.  Predicting erectile dysfunction in sexually active patients seeking prostate health screening: proposal for a multivariable risk stratification.

Authors:  V Favilla; G I Russo; G Reale; S Leone; T Castelli; S La Vignera; R A Condorelli; A E Calogero; S Cimino; G Morgia
Journal:  Int J Impot Res       Date:  2015-07-30       Impact factor: 2.896

Review 7.  A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction.

Authors:  Konstantinos Hatzimouratidis
Journal:  Ther Adv Urol       Date:  2014-08

8.  The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction.

Authors:  Mauro Gacci; Matteo Salvi; Arcangelo Sebastianelli; Linda Vignozzi; Giovanni Corona; Kevin T McVary; Steven A Kaplan; Mario Maggi; Marco Carini; Matthias Oelke
Journal:  Res Rep Urol       Date:  2013-04-06

9.  Depressive symptoms in patients diagnosed with benign prostatic hyperplasia.

Authors:  Barbara Pietrzyk; Magdalena Olszanecka-Glinianowicz; Aleksander Owczarek; Tomasz Gabryelewicz; Agnieszka Almgren-Rachtan; Andrzej Prajsner; Jerzy Chudek
Journal:  Int Urol Nephrol       Date:  2015-02-12       Impact factor: 2.370

10.  Lower urinary tract symptoms and erectile dysfunction in men with type 2 diabetes mellitus.

Authors:  Hyo Jeong Song; Eun Joo Lee; Nancy Bergstrom; Duck-Hee Kang; Dae Ho Lee; Gwangpyo Koh; Jung-Sik Huh; Sung Dae Kim; Seong Cheol Hong; Seong Sil Moon; Jiyoung Kang
Journal:  Int Neurourol J       Date:  2013-12-31       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.